About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Critical Reviews in Oncology/Hematology
›
Top Articles
Critical Reviews in Oncology/Hematology
Hematology
,
Oncology
7
(top 2%)
Impact Factor
7.6
(top 2%)
extended IF
131
(top 2%)
H-Index
3.1K
authors
3.4K
papers
119.6K
citations
7.6K
citing journals
79.3K
citing authors
Most Cited Articles of Critical Reviews in Oncology/Hematology
Title
Year
Citations
Epidermal growth factor-related peptides and their receptors in human malignancies
1995
2.2K
The cellular and molecular basis of hyperthermia
2002
1.2K
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
2005
828
The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer
2013
827
Nickel essentiality, toxicity, and carcinogenicity
2002
740
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages
2008
699
Stem cell origin of cancer and differentiation therapy
2004
509
Employment and work-related issues in cancer survivors
2011
500
Vanadium in cancer treatment
2002
469
Mechanisms of resistance to cisplatin and carboplatin
2007
458
Vascular endothelial growth factor (VEGF) signaling in tumor progression
2007
442
Cathepsin D--many functions of one aspartic protease
2008
428
TIMPs as multifacial proteins
2004
404
Radiation-associated cardiovascular disease
2003
393
Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
2001
381
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study
2008
380
Regulation of angiogenesis by hypoxia-inducible factor 1
2006
374
Circulating microRNAs: Association with disease and potential use as biomarkers
2011
372
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update
2012
350
Use of L-asparaginase in childhood ALL
1998
337
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation
2005
330
Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study
2010
319
Gastric cancer
2009
316
Multicellular resistance: a paradigm for clinical resistance?
2000
309
Nutritional support of the cancer patient: issues and dilemmas
2000
299
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.